AtaiBeckley Inc. ATAI
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-06-18
AtaiBeckley Inc. statistics & valuation
Market cap$1.9B
P / B8.8×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 |
|---|---|---|
| Operating margin | -15751.1% | -33341.2% |
| Net margin | -16142.0% | -48464.0% |
| FCF margin | -2533.0% | -26767.2% |
| Return on assets | -225.5% | -93.7% |
| Return on equity | -297.3% | -128.1% |
| Debt / equity | 0.00× | 0.12× |
| Current ratio | 11.74 | 3.21 |
| Revenue growth | 1227.6% | — |
Source: SEC EDGAR filings · CIK 0002081043 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.